These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 23143801)

  • 1. Variation in selenoenzyme genes and prostate cancer risk and survival.
    Geybels MS; Hutter CM; Kwon EM; Ostrander EA; Fu R; Feng Z; Stanford JL; Peters U
    Prostate; 2013 May; 73(7):734-42. PubMed ID: 23143801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variation in the selenoenzyme genes and risk of advanced distal colorectal adenoma.
    Peters U; Chatterjee N; Hayes RB; Schoen RE; Wang Y; Chanock SJ; Foster CB
    Cancer Epidemiol Biomarkers Prev; 2008 May; 17(5):1144-54. PubMed ID: 18483336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selenoprotein and antioxidant genes and the risk of high-grade prostate cancer and prostate cancer recurrence.
    Gerstenberger JP; Bauer SR; Van Blarigan EL; Sosa E; Song X; Witte JS; Carroll PR; Chan JM
    Prostate; 2015 Jan; 75(1):60-9. PubMed ID: 25284284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of genetic variations of selenoprotein genes, plasma selenium levels, and prostate cancer aggressiveness at diagnosis.
    Xie W; Yang M; Chan J; Sun T; Mucci LA; Penney KL; Lee GS; Kantoff PW
    Prostate; 2016 May; 76(7):691-9. PubMed ID: 26847995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate cancer (PCa) risk variants and risk of fatal PCa in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.
    Shui IM; Lindström S; Kibel AS; Berndt SI; Campa D; Gerke T; Penney KL; Albanes D; Berg C; Bueno-de-Mesquita HB; Chanock S; Crawford ED; Diver WR; Gapstur SM; Gaziano JM; Giles GG; Henderson B; Hoover R; Johansson M; Le Marchand L; Ma J; Navarro C; Overvad K; Schumacher FR; Severi G; Siddiq A; Stampfer M; Stevens VL; Travis RC; Trichopoulos D; Vineis P; Mucci LA; Yeager M; Giovannucci E; Kraft P
    Eur Urol; 2014 Jun; 65(6):1069-75. PubMed ID: 24411283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selenoprotein gene variants, toenail selenium levels, and risk for advanced prostate cancer.
    Geybels MS; van den Brandt PA; Schouten LJ; van Schooten FJ; van Breda SG; Rayman MP; Green FR; Verhage BA
    J Natl Cancer Inst; 2014 Mar; 106(3):dju003. PubMed ID: 24563517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selenoprotein P genetic variants and mrna expression, circulating selenium, and prostate cancer risk and survival.
    Penney KL; Li H; Mucci LA; Loda M; Sesso HD; Stampfer MJ; Ma J
    Prostate; 2013 May; 73(7):700-5. PubMed ID: 23129481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A large prospective study of SEP15 genetic variation, interaction with plasma selenium levels, and prostate cancer risk and survival.
    Penney KL; Schumacher FR; Li H; Kraft P; Morris JS; Kurth T; Mucci LA; Hunter DJ; Kantoff PW; Stampfer MJ; Ma J
    Cancer Prev Res (Phila); 2010 May; 3(5):604-10. PubMed ID: 20424130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic variation in GPX1 is associated with GPX1 activity in a comprehensive analysis of genetic variations in selenoenzyme genes and their activity and oxidative stress in humans.
    Takata Y; King IB; Lampe JW; Burk RF; Hill KE; Santella RM; Kristal AR; Duggan DJ; Vaughan TL; Peters U
    J Nutr; 2012 Mar; 142(3):419-26. PubMed ID: 22259188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma antioxidants, genetic variation in SOD2, CAT, GPX1, GPX4, and prostate cancer survival.
    Van Blarigan EL; Ma J; Kenfield SA; Stampfer MJ; Sesso HD; Giovannucci EL; Witte JS; Erdman JW; Chan JM; Penney KL
    Cancer Epidemiol Biomarkers Prev; 2014 Jun; 23(6):1037-46. PubMed ID: 24711484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Confirmation of genetic variants associated with lethal prostate cancer in a cohort of men from hereditary prostate cancer families.
    Karyadi DM; Zhao S; He Q; McIntosh L; Wright JL; Ostrander EA; Feng Z; Stanford JL
    Int J Cancer; 2015 May; 136(9):2166-71. PubMed ID: 25273821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Germline variants in IL4, MGMT and AKT1 are associated with prostate cancer-specific mortality: An analysis of 12,082 prostate cancer cases.
    FitzGerald LM; Zhao S; Leonardson A; Geybels MS; Kolb S; Lin DW; Wright JL; Eeles R; Kote-Jarai Z; Govindasami K; Giles GG; Southey MC; Schleutker J; Tammela TL; Sipeky C; Penney KL; Stampfer MJ; Gronberg H; Wiklund F; Stattin P; Hugosson J; Karyadi DM; Ostrander EA; Feng Z; Stanford JL
    Prostate Cancer Prostatic Dis; 2018 Jun; 21(2):228-237. PubMed ID: 29298992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CYP17 polymorphisms and prostate cancer outcomes.
    Wright JL; Kwon EM; Lin DW; Kolb S; Koopmeiners JS; Feng Z; Ostrander EA; Stanford JL
    Prostate; 2010 Jul; 70(10):1094-101. PubMed ID: 20503394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SEPP1 influences breast cancer risk among women with greater native american ancestry: the breast cancer health disparities study.
    Pellatt AJ; Wolff RK; John EM; Torres-Mejia G; Hines LM; Baumgartner KB; Giuliano AR; Lundgreen A; Slattery ML
    PLoS One; 2013; 8(11):e80554. PubMed ID: 24278290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Common genetic variation of the calcium-sensing receptor and lethal prostate cancer risk.
    Shui IM; Mucci LA; Wilson KM; Kraft P; Penney KL; Stampfer MJ; Giovannucci E
    Cancer Epidemiol Biomarkers Prev; 2013 Jan; 22(1):118-26. PubMed ID: 23125333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic variants in the TEP1 gene are associated with prostate cancer risk and recurrence.
    Gu C; Li Q; Zhu Y; Qu Y; Zhang G; Wang M; Yang Y; Wang J; Jin L; Wei Q; Ye D
    Prostate Cancer Prostatic Dis; 2015 Dec; 18(4):310-6. PubMed ID: 26238235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glutathione peroxidase tagSNPs: associations with rectal cancer but not with colon cancer.
    Haug U; Poole EM; Xiao L; Curtin K; Duggan D; Hsu L; Makar KW; Peters U; Kulmacz RJ; Potter JD; Koepl L; Caan BJ; Slattery ML; Ulrich CM
    Genes Chromosomes Cancer; 2012 Jun; 51(6):598-605. PubMed ID: 22371331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of HOTAIR rs920778 and rs12826786 genetic variants on prostate cancer risk and progression-free survival.
    Oliveira AI; Xavier-Magalhães A; Moreira-Barbosa C; Magalhães H; Henrique R; Jerónimo C; Costa BM
    Biomark Med; 2018 Mar; 12(3):257-264. PubMed ID: 29436234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Common germline genetic variation in antioxidant defense genes and survival after diagnosis of breast cancer.
    Udler M; Maia AT; Cebrian A; Brown C; Greenberg D; Shah M; Caldas C; Dunning A; Easton D; Ponder B; Pharoah P
    J Clin Oncol; 2007 Jul; 25(21):3015-23. PubMed ID: 17634480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Replication of a genetic variant for prostate cancer-specific mortality.
    Penney KL; Shui IM; Feng Z; Sesso HD; Stampfer MJ; Stanford JL
    Prostate Cancer Prostatic Dis; 2015 Sep; 18(3):260-3. PubMed ID: 25939514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.